SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-049427
Filing Date
2021-12-22
Accepted
2021-12-22 18:21:47
Documents
1
Period of Report
2021-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3660
  Complete submission text file 0000899243-21-049427.txt   5005
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SELECTA BIOSCIENCES, INC. 480 ARSENAL WAY WATERTOWN MA 02472
Business Address
Dahms Bradford D. (Reporting) CIK: 0001787307 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 211514345